Syntaxin-2 (STX2)

Syntaxin-2 is a member of the syntaxin/epimorphin family and is encoded by the STX2 gene in humans[1]. As a Qa-SNARE protein, its canonical function is to regulate the targeting and fusion of intracellular transport vesicles, participating directly in the SNARE complex responsible for membrane fusion in exocytosis and vesicular trafficking[1][2]. In epithelial tissues, Syntaxin-2 mediates epithelial-mesenchymal interactions and regulates cell morphogenesis and activation; when oriented with its N-terminus extracellularly via non-classical secretion, it functions as the morphogen epimorphin[1]. Syntaxin-2 is required for mucin secretion and is involved in biphasic release pathways for both mucins and insulin in secretory cells, acting in a regulated manner in combination with SNARE partners such as VAMP-8 and modulatory proteins like tetraspanin-8[3]. In the nervous system and retina, STX2 is predominantly expressed in amacrine cells, though its precise functional roles in neuronal exocytosis and retinal physiology remain incompletely understood[2]. It is implicated in diseases associated with secretory dysfunction and epithelial morphogenesis, including cancer and metabolic or inflammatory processes[1][3]. STX2 interacts with proteins such as SNAP-25, SNAP23, STXBP1, and syntaxin-binding protein 3[1]. No approved drugs targeting Syntaxin-2 are currently recognized, and no established clinical biomarkers are reported. Disturbances in STX2-mediated pathways could pose safety risks due to broad involvement in essential vesicular transport and secretion[1][3].

Other names

Syntaxin-2STX2EpimorphinEPIMEPMSTX2ASTX2BSTX2Cepimorphin

SNARE complex modulation (mediating or inhibiting membrane fusion events) Interaction with tetraspanins to regulate secretory granule fusion